Case study
Strategic Insights into Eosinophilic Esophagitis Therapy Development and Digital Product Launches
Explore strategic insights into Eosinophilic Esophagitis therapy development and digital product launches. Learn from key opinion leaders and industry experts about unmet needs, disease burden, and best practices for successful digital marketing in the pharmaceutical industry.

- Europe
- Pharma
CHALLENGE
A leading strategy consulting firm sought our expertise for a project focused on the development of therapies for Eosinophilic Esophagitis. The project had a dual focus: understanding countries' perceptions of unmet needs and the burden of the disease, as well as raising awareness about the condition. Additionally, the client aimed to explore how pharmaceutical companies conduct digital product launches, identify key success factors and challenges, and understand the necessary tools and capabilities.
OUR APPROACH
BTHT embarked on a thorough strategic analysis to address the multifaceted project scope. This involved a detailed examination of both the medical and digital marketing landscapes relevant to Eosinophilic Esophagitis therapy development. The research team sourced insights from industry professionals and key opinion leaders (KOLs) to provide a comprehensive perspective. The research team engaged with experts possessing extensive knowledge of Eosinophilic Esophagitis, including: - Members of the European Society of Eosinophilic Esophagitis - Specialist doctors in Eosinophilic gastrointestinal disorders
Simultaneously, our team connected with industry professionals who had substantial experience in digital product launches and omnichannel strategies within the pharmaceutical sector, such as: - Former Digital Lead UK & Former Global Launch Excellence Lead at a major pharmaceutical company - Digital Lead European Central Cluster at a major pharmaceutical company - Customer Experience and Digital Transformation Lead Mid-Europe from a major pharmaceutical company
These experts provided insights into the unmet needs and disease burden in Europe, as well as the best practices and challenges associated with digital product launches. BTHT team arranged and also participated in the consultations to ensure all the process proceeded smoothly.
OUTCOME
Comprehensive and strategic approach of BTHT delivered valuable insights for the client. Through focused consultations with both medical and digital marketing experts, our team equipped the client with a deep understanding of Eosinophilic Esophagitis and the critical factors for successful digital product launches. This enabled the client to make informed decisions, develop effective strategies, and navigate the complexities of both therapy development and digital marketing in the pharmaceutical industry.
Let's talk about your project
Reach our CEO Alexis Capelle directly or send us a message — we typically reply within one business day.